EX-99.1 6 v131117_ex99-1.htm Unassociated Document
Exhibit 99.1
 

Contact:    Daniel C. Dunn
Chief Financial Officer
(314) 771-2400
 
 
Allied Healthcare Net Income Increases
 
ST. LOUIS, NOVEMBER 7, 2008 – Allied Healthcare Products Inc. (NASDAQ: AHPI) reported that its net income for the first quarter ending September 30 increased 139 percent, from about $87,000 last year, or about 1 cent per share, to about $208,000 in the current quarter, or about 3 cents per share, primarily on increased sales.

Net sales for the first quarter of the company’s 2009 fiscal year improved by about 2.4 percent, or $340,000 to $14.4 million. Actual orders for the quarter were only slightly ahead of last year. However, Allied increased net sales by working down its backlog of orders.

While prices for commodities such as sheet steel and brass increased more than 6 percent over last year’s average costs, Allied achieved price reductions for non-commodity items such as electronics and plastic components that helped offset the increases in commodity prices, enhancing margins. Selective price increases totaling about 2 percent over the previous year also boosted Allied margins.

Allied introduced the first in a line of mass casualty ventilators in October. The devices, designed specifically for use in pandemics, natural disasters or terrorist attacks, will be launched throughout the 2009 fiscal year.

Allied Healthcare Products, Inc. manufactures a variety of respiratory products used in the healthcare industry in a range of hospital and alternate care site settings including sub-acute care facilities, home healthcare and emergency medical care. The Company’s product lines include respiratory care products, medical gas equipment and emergency medical products. Its products are marketed to hospitals, hospital equipment dealers, hospital construction contractors, home healthcare dealers and emergency medical products dealers.



“SAFE HARBOR” STATEMENT: Statements contained in this release that are not historical facts or information are “forward-looking statements.” Words such as “believe,” “expect,” “intend,” “will,” “should,” and other expressions that indicate future events and trends identify such forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome and future results of operations and financial condition to be materially different than stated or anticipated based on the forward-looking statements. Such risks and uncertainties include both general economic risks and uncertainties, risks and uncertainties affecting the demand for and economic factors affecting the delivery of health care services, and specific matters which relate directly to the Company’s operations and properties as discussed in its periodic filings with the Securities and Exchange Commission. The Company cautions that any forward-looking statement contained in this report reflects only the belief of the Company or its management at the time the statement was made. Although the Company believes such forward-looking statements are based upon reasonable assumptions, such assumptions may ultimately prove inaccurate or incomplete. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement was made.

##



ALLIED HEALTHCARE PRODUCTS, INC.
CONSOLIDATED STATEMENT OF OPERATIONS
(UNAUDITED)

   
Three months ended September 30,
 
   
2008
 
2007
 
           
Net sales
 
$
14,441,011
 
$
14,101,618
 
Cost of sales
   
10,939,957
   
10,934,605
 
               
Gross profit
   
3,501,054
   
3,167,013
 
               
Selling, general and administrative expenses
   
3,183,587
   
3,042,969
 
               
Income from operations
   
317,467
   
124,044
 
               
Interest income
   
(30,659
)
 
(40,769
)
Other expense, net
   
12,067
   
15,150
 
     
(18,592
)
 
(25,619
)
               
Income before provision for income taxes
   
336,059
   
149,663
 
               
Provision for income taxes
   
127,702
   
62,597
 
Net income
 
$
208,357
 
$
87,066
 
               
Basic and diluted earnings per share
 
$
0.03
 
$
0.01
 
               
Weighted average common shares
             
Outstanding - Basic
   
7,891,232
   
7,883,577
 
               
Weighted average common shares
             
Outstanding - Diluted
   
8,132,931
   
8,106,796
 
 


ALLIED HEALTHCARE PRODUCTS, INC.
CONSOLIDATED BALANCE SHEET
(UNAUDITED)

   
September 30, 2008
 
June 30, 2008
 
ASSETS
         
Current assets:
         
Cash and cash equivalents
 
$
4,124,456
 
$
6,149,015
 
Accounts receivable, net of allowances of $300,000
   
6,372,369
   
6,441,683
 
Inventories, net
   
12,776,424
   
12,046,450
 
Other current assets
   
554,744
   
394,975
 
Total current assets
   
23,827,993
   
25,032,123
 
Property, plant and equipment, net
   
11,174,253
   
10,542,573
 
Goodwill
   
15,979,830
   
15,979,830
 
Other assets, net
   
700,267
   
703,328
 
Total assets
 
$
51,682,343
 
$
52,257,854
 
               
LIABILITIES AND STOCKHOLDERS' EQUITY
             
Current liabilities:
             
Accounts payable
 
$
2,726,387
 
$
2,590,804
 
Other accrued liabilities
   
2,124,890
   
2,960,334
 
Deferred income taxes
   
523,226
   
500,238
 
Deferred revenue
   
690,000
   
690,000
 
Total current liabilities
   
6,064,503
   
6,741,376
 
               
Deferred revenue
   
2,005,000
   
2,177,500
 
               
Commitments and contingencies
             
               
Stockholders' equity:
             
Preferred stock; $0.01 par value; 1,500,000 shares authorized; no shares issued and outstanding
   
-
   
-
 
Series A preferred stock; $0.01 par value; 200,000 shares authorized; no shares issued and outstanding
   
-
   
-
 
Common stock; $0.01 par value; 30,000,000 shares authorized; 10,204,819 and 10,188,569 shares issued at September 30, 2008 and June 30, 2008, respectively; 7,901,327 and 7,885,077 shares outstanding at September 30, 2008 and June 30, 2008, respectively
   
102,048
   
101,886
 
Additional paid-in capital
   
47,589,427
   
47,524,084
 
Retained earnings
   
16,652,793
   
16,444,436
 
Less: treasury stock, at cost; 2,303,492 shares at
             
September 30, 2008 and June 30, 2008, respectively
   
(20,731,428
)
 
(20,731,428
)
Total stockholders' equity
   
43,612,840
   
43,338,978
 
Total liabilities and stockholders' equity
 
$
51,682,343
 
$
52,257,854